RSV Vaccines Are Coming At Last: Your He...

In this episode of Science Quickly, we explore newly released 9/11 records and their revelations about the attacks’ lasting health impacts, unpack a controversial artificial intelligence breakthrough that solved one of mathematics’ biggest problems and examine the growing backlas ... Show More

Can an artificial intelligence really be a friend? In this episode of Science Quickly, Scientific American books and culture lead Bri Kane sits down with Massachusetts Institute of Technology researcher Sherry Turkle to discuss the rise of AI chatbots and their effect on human co ... Show More

Friendships are key to our well-being, but what kind of friendships do we really want? Despite being such a foundational part of the human experience, the science of friendship is still mysterious. Assistant professor of psychology Jessica Ayers is trying to fill in the blanks. W ... Show More

A respiratory virus called RSV has a lot of kids in critical condition and hospitals overwhelmed. Vox public health reporter and epidemiologist Keren Landman explains newfound hope for a vaccine. This episode was produced by Victoria Chamberlin, edited by Matt Collette, fact-chec ... Show More

Welcome to a special series by Respiratory Exchange Addressing the Impact of RSV and Vaccine Hesitancy. In this series, we explore the efficacy of RSV vaccines and discuss preventive strategies aimed at reducing the occurrence of severe RSV respiratory illness in infants, childre ... Show More

In this episode, we briefly review RSV (respiratory syncytial virus) infections and focus on new data supporting the use of two different RSV vaccines (Abrysvo and Arvexy) in preventing RSV infections in older adults and in pregnant women. Key Concepts RSV is a contagious respira ... Show More

Dr. Michaela Gack explains her research on emerging respiratory viruses and vector-borne pathogens. She discusses the recent advancements in RSV vaccine development while addressing the challenges in RSV epidemiology, vaccination strategies and the importance of education, messag ... Show More

COVID, flu and RSV are surging. Here’s what you need to know to protect yourself. Learn more about your ad choices. Visit megaphone.fm/adchoices 

The Food and Drug Administration has authorized a vaccine by Pfizer and BioNTech that will start reaching the most at-risk Americans today. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks through the final hurdles the vaccine had to clear over the weekend. To learn more ab ... Show More

A recent vaccine trial from Oxford University shows promising preliminary results, suggesting the vaccine can produce immune responses that may protect people against infection. Dr. Sanjay Gupta spoke with Dr. Barney Graham, the deputy director of the Vaccine Research Center at t ... Show More

There's a lot of misinformation going around about a "brand new" vaccine, but mRNA vaccines have been worked on since the 1970's. Luckily they were perfected just in time for the biggest crisis in modern history. Learn about how mRNA vaccines work and what one dedicated pediatric ... Show More